BioBeat - Xconomy

Entry	Author	Date	Location
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers	Luke Timmerman	05/21/12	National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show	Luke Timmerman	05/14/12	National
Antibiotic R&D is in Trouble: Here’s One Way to Fix It	Luke Timmerman	05/07/12	National
SD Life Sciences Roundup: Gen-Probe, Zogenix, & the Innovation Economy	Bruce V. Bigelow	05/03/12	San Diego
Biotech IPOs Start to Show Some Modest Signs of Life	Luke Timmerman	04/30/12	National
What Are the Hottest Targets in Biotech Today?	Luke Timmerman	04/23/12	National
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1	Luke Timmerman	04/16/12	National
Investing in Biotech Isn’t Just for Investors Anymore	Luke Timmerman	04/09/12	National
Biotech Can’t Sidestep Cost-Effectiveness Anymore	Luke Timmerman	04/02/12	National
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks	Luke Timmerman	03/26/12	National
Biotech’s New Frontier: Europe?	Luke Timmerman	03/19/12	National
Life Sciences News Roundup: InflammaGen, HemaQuest, ImThera & More	Bruce V. Bigelow	03/16/12	San Diego
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals	Luke Timmerman	03/12/12	National
San Diego Life Sciences Roundup: Aragon, Illumina, CareFusion, & More	Bruce V. Bigelow	03/08/12	San Diego
Five Reasons Illumina Should Fight Roche’s Insulting Low-Ball Bid	Luke Timmerman	03/05/12	National
Bruce Booth, a LifeSciVC Shining Some Much-Needed Light on Biotech	Luke Timmerman	02/27/12	National
Oh, And One More Thing: A Wowser Moment in DNA Sequencing	Luke Timmerman	02/21/12	National
Xconomy’s Timmerman Wins National Journalism Award	Curt Woodward	02/17/12	National
Never Back Smug: A Lesson for Life Sciences From Newt Gingrich	Luke Timmerman	01/30/12	National
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More	Bruce V. Bigelow	01/26/12	San Diego
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting	Luke Timmerman	01/23/12	National
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More	Bruce V. Bigelow	01/12/12	San Diego
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference	Luke Timmerman	01/09/12	National
Amgen CEO Kevin Sharer’s Report Card: C	Luke Timmerman	12/19/11	National
The Hepatitis C Market: Biotech’s Version of the Daytona 500	Luke Timmerman	12/12/11	National
Steve Jobs’s Dying Realization About Biology and Technology	Luke Timmerman	12/05/11	National
Buyouts, Quantified Health, & More San Diego Life Sciences News	Bruce V. Bigelow	12/01/11	San Diego
Versant Ventures’ Partner Cuts Back on Biotech Work to Spend Time With Family. For Real	Luke Timmerman	11/28/11	National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2)	Luke Timmerman	11/22/11	National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 1)	Luke Timmerman	11/21/11	National
Page 1 of 3	next page »

Entry

Author

Date

Location

Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers

Luke Timmerman

05/21/12

National

ASCO Preview: Eight Cancer Drugs to Watch at the Big Show

Luke Timmerman

05/14/12

National